Adoptive cell therapy: Living drugs against cancer.

Adoptive cell therapy: Living drugs against cancer.
复制标题

DOI:
10.1084/jem.20200377
复制
发表时间:
2020-12-07
期刊:
The Journal of experimental medicine
影响因子:
--
通讯作者:
Rezvani K
Rezvani K
中科院分区:
其他
文献类型:
--
作者:
Laskowski T;Rezvani K

文献摘要

参考文献

被引文献

相似文献

Tamara Laskowski和Katayoun Rezvani讨论了癌症过继细胞疗法的最新进展。在过去的十年里,免疫疗法对癌症的治疗产生了深远的影响。对免疫细胞和癌症之间错综复杂的关系的研究洞察到,临床上已经开发出重新引导免疫系统的力量来靶向和消除癌症的策略。今天,免疫疗法代表着一种迅速扩张和变革的力量,包括多种方式。
Tamara Laskowski and Katayoun Rezvani discuss the recent advances of adoptive cell therapy in cancer. Immunotherapy has made a profound impact in the treatment of cancer in the last decade. Insights from the study of the intricate relationships between immune cells and cancer have led to the clinical development of strategies that redirect the power of the immune system to target and eliminate cancer. Today, immunotherapy represents a rapidly expanding and transformative force comprising multiple modalities.
DOI: 10.1016/j.tibtech.2011.04.009
发表时间: 2011-11
影响因子: 17.3
作者:
Park, Tristen S.;Rosenberg, Steven A.;Morgan, Richard A.
通讯作者: Morgan, Richard A.
DOI: 10.1182/blood-2011-11-392951
发表时间: 2012-04-19
期刊: BLOOD
影响因子: 20.3
作者:
Ndhlovu, Lishomwa C.;Lopez-Verges, Sandra;Lanier, Lewis L.
通讯作者: Lanier, Lewis L.
DOI: 10.3389/fimmu.2018.00385
发表时间: 2018
影响因子: 7.3
作者:
Lichtenegger FS;Rothe M;Schnorfeil FM;Deiser K;Krupka C;Augsberger C;Schlüter M;Neitz J;Subklewe M
通讯作者: Subklewe M
DOI: 10.1056/nejmoa1910607
发表时间: 2020-02-06
影响因子: 158.5
作者:
Liu, Enli;Marin, David;Rezvani, Katayoun
通讯作者: Rezvani, Katayoun
DOI: 10.1038/s41591-020-1074-2
发表时间: 2020-10-12
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Heczey, Andras;Courtney, Amy N.;Metelitsa, Leonid S.
通讯作者: Metelitsa, Leonid S.